PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
308.03%
Net income growth above 1.5x MCHP's 7.59%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-1.58%
Both reduce yoy D&A, with MCHP at -0.69%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-13.89%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-100.00%
Both cut yoy SBC, with MCHP at -100.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-34.38%
Negative yoy working capital usage while MCHP is 279.52%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
100.00%
AR growth well above MCHP's 100.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-56.14%
Both reduce yoy inventory, with MCHP at -5654.05%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
100.00%
A yoy AP increase while MCHP is negative at -100.00%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-804.76%
Negative yoy usage while MCHP is 411.06%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-2998.00%
Both negative yoy, with MCHP at -24.04%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
14.72%
Operating cash flow growth similar to MCHP's 16.03%. Walter Schloss would see parallel improvements or market conditions in cash generation.
8.33%
Lower CapEx growth vs. MCHP's 29.89%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
84.18%
Acquisition spending well above MCHP's 22.95%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-165.98%
Both yoy lines negative, with MCHP at -68.62%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-15.46%
Both yoy lines are negative, with MCHP at -29.17%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
49700.00%
Growth well above MCHP's 69.84%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
146.91%
We have mild expansions while MCHP is negative at -634.44%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
11.58%
Debt repayment growth of 11.58% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-3.52%
Negative yoy issuance while MCHP is 19.27%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
27.99%
Buyback growth of 27.99% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.